Clinical Trials Browser

Phase 2/3 × Sitagliptin Phosphate × Clear all

NCT05972928 2023-08-02

Effect of Sitagliptin on Polycystic Ovarian Syndrome Patients

Phase 2/3 Unknown

Polycystic Ovary Syndrome